Vaso Corporation is a small healthcare-focused company operating three distinct businesses. The largest segment, VasoHealthcare, acts as an exclusive sales representative for GE HealthCare, selling diagnostic imaging and ultrasound equipment to smaller hospitals, clinics, and physician groups across the continental U.S. that GEHC's own direct sales force does not prioritize. VasoHealthcare earns commissions on equipment sales and fees on service agreements and financing, with revenue driven by the volume and size of deals closed by its roughly 80-person salesforce. This segment is entirely dependent on a single supplier agreement with GEHC, currently extended through December 2030. The second segment, VasoTechnology, operates through NetWolves, which provides managed network infrastructure, transport, and security services to businesses by aggregating capacity from over 175 carrier partners into a single bundled solution. NetWolves generates recurring contract revenue driven by the number of customers under contract and scope of services. The third segment, VasoMedical, designs and sells proprietary cardiovascular diagnostic devices — including Holter monitors, blood pressure recorders, and wireless vital signs monitors — alongside the ARCS cloud-based ECG analysis software platform. VasoMedical sells hardware outright and generates recurring SaaS revenue from ARCS, with products distributed in the U.S., China, and internationally. Vaso divested its healthcare IT business in late 2025 and retains a minority stake in its former EECP therapy business.